Ironwood Pharmaceuticals

Listing Websites about Ironwood Pharmaceuticals

Filter Type:

Home - Ironwood Pharmaceuticals

(7 days ago) Ironwood is a healthcare company dedicated to making a difference for people living with gastrointestinal (GI) diseases Ironwood Pharmaceuticals. Media Releases. January 10, 2022. Ironwood Pharmaceuticals Provides Update on FY 2021 Financial Guidance and Announces FY 2022 Financial Guidance.

Ironwoodpharma.com

Category:  Pharmaceutical,  Health Detail Drugs


Ironwood Pharmaceuticals, Inc. (IRWD) Stock Price, News

(6 days ago) Ironwood Pharmaceuticals Provides Update on FY 2021 Financial Guidance and Announces FY 2022 Financial Guidance. BOSTON, January 10, 2022--Ironwood Pharmaceuticals, Inc. (Nasdaq: IRWD), a GI

Finance.yahoo.com

Category:  Pharmaceutical Detail Drugs


Ironwood Pharmaceuticals, Inc. - Investor Home

(3 days ago) At Ironwood Pharmaceuticals, Inc., we strive to treat your data with respect and will not share your information with any third party. You can unsubscribe to any of the investor alerts you are subscribed to by visiting the ‘unsubscribe’ section below. If you experience any issues with this process, please contact us for further assistance.

Investor.ironwoodpharma.com

Category:  Pharmaceutical Detail Drugs


The countdown is on: Ironwood Pharmaceuticals Inc. (IRWD

(3 days ago) Ironwood Pharmaceuticals Inc. (IRWD) is priced at $10.85 after the most recent trading session. At the very opening of the session, the stock price was $11.23 and reached a high price of $11.51, prior to closing the session it reached the value of $11.14. The stock touched a low price of $10.79.Rece

Investchronicle.com

Category:  Pharmaceutical Detail Drugs


Ironwood Pharmaceuticals (IRWD)

(8 days ago) Ironwood Pharmaceuticals (IRWD) Shares Cross Above 200 DMA. In trading on Thursday, shares of Ironwood Pharmaceuticals Inc. (NASD: IRWD) crossed above their 200 day moving average of $13.66

Forbes.com

Category:  Pharmaceutical Detail Drugs


Our Pipeline - Ironwood Pharmaceuticals

(6 days ago) Partnering Opportunities. As a GI focused, US healthcare company, we are interested in discussing opportunities to collaborate on GI products. We are also seeking partners in territories outside of the US for select current development programs. Please contact us with more details on your area of interest.

Ironwoodpharma.com

Category:  Health Detail Drugs


IRWD Stock Price Ironwood Pharmaceuticals Inc. Cl A

(8 days ago) Ironwood Pharmaceuticals, Inc. is a healthcare company, which focuses on the development and commercialization of Gastrointestinal (GI) product opportunities in areas of significant unmet need

Marketwatch.com

Category:  Pharmaceutical,  Health Detail Drugs


Zacks: Brokerages Expect Ironwood Pharmaceuticals, Inc

(1 days ago) Ironwood Pharmaceuticals, Inc is a healthcare company, which focuses on the development and commercialization of Gastrointestinal (GI) product opportunities in areas of significant unmet need

Etfdailynews.com

Category:  Pharmaceutical,  Health Detail Drugs


Ironwood Pharmaceuticals - Wikipedia

(4 days ago) Ironwood Pharmaceuticals, Inc is a publicly traded pharmaceutical company. It was originally called Microbia, Inc. Microbia was founded by postdocs from the lab of Gerald Fink at the Whitehead Institute to commercialize approaches that had been developed in the lab to improve industrial fermentation of fungi, to genetically engineer them to produce secondary metabolites …

En.wikipedia.org

Category:  Pharmaceutical Detail Drugs


Ironwood Pharmaceuticals Provides Update on FY 2021

(8 days ago) Ironwood Pharmaceuticals (Nasdaq: IRWD) is a leading gastrointestinal (GI) healthcare company on a mission to advance the treatment of GI diseases and redefine the standard of care for GI patients

Businesswire.com

Category:  Pharmaceutical,  Health Detail Drugs


Ironwood Pharmaceuticals to Present at the 40th Annual J.P

(7 days ago) Ironwood Pharmaceuticals (Nasdaq: IRWD) is a leading gastrointestinal (GI) healthcare company on a mission to advance the treatment of GI diseases and redefine the standard of care for GI patients

Businesswire.com

Category:  Pharmaceutical,  Health Detail Drugs


Morning Buzz: Symantec (SYMC), Ironwood Pharmaceuticals

(6 days ago) Shares of Ironwood Pharmaceuticals, Inc. (IRWD) up more than 2% this morning after Ironwood Pharma and AstraZeneca announced that top-line data from a Phase III clinical trial of adults with

Wallstreetpit.com

Category:  Pharmaceutical Detail Drugs


Ironwood Pharmaceuticals LinkedIn

(7 days ago) Ironwood Pharmaceuticals Pharmaceuticals Boston, MA 25,870 followers Ironwood is on a mission to advance treatment of gastrointestinal diseases …

Linkedin.com

Category:  Pharmaceutical Detail Drugs


Ironwood Pharmaceuticals Appoints Sravan K. Emany as Chief

(7 days ago) Ironwood Pharmaceuticals (Nasdaq: IRWD) is a leading gastrointestinal (GI) healthcare company on a mission to advance the treatment of GI diseases and redefine the standard of care for GI patients

Businesswire.com

Category:  Pharmaceutical,  Health Detail Drugs


Ironwood Pharmaceuticals, Inc. - Press Releases

(3 days ago) At Ironwood Pharmaceuticals, Inc., we strive to treat your data with respect and will not share your information with any third party. You can unsubscribe to any of the investor alerts you are subscribed to by visiting the ‘unsubscribe’ section below. If you experience any issues with this process, please contact us for further assistance.

Investor.ironwoodpharma.com

Category:  Pharmaceutical Detail Drugs


IRONWOOD PHARMACEUTICALS A AKTIE News Aktienkurs

(3 days ago) Ironwood Pharmaceuticals A Chart. Der Dividenden-Chartvergleich zeigt die Rendite inklusive der Ausschüttungen (Aktienkurs + Dividende, grün) im Vergleich zum Aktienkurs (blau) und so die

Finanzen.net

Category:  Pharmaceutical Detail Drugs


Ironwood Pharmaceuticals - Crunchbase Company Profile

(4 days ago) Ironwood Pharmaceuticals is an entrepreneurial pharmaceutical company, engages in developing and marketing human medicines. It engages in developing a pipeline of clinical candidates in the areas of gastrointestinal diseases, cardiovascular diseases, pain, …

Crunchbase.com

Category:  Pharmaceutical Detail Drugs


Thomas A. Mccourt Sells 46,327 Shares of Ironwood

(5 days ago) Ironwood Pharmaceuticals, Inc is a healthcare company, which focuses on the development and commercialization of Gastrointestinal (GI) product opportunities in areas of significant unmet need

Etfdailynews.com

Category:  Pharmaceutical,  Health Detail Drugs


135 Salaries at Ironwood Pharmaceuticals Shared by

(8 days ago) The average Ironwood Pharmaceuticals salary ranges from approximately $101,903 per year for a Senior Associate Scientist to $229,707 per year for a Director. Ironwood Pharmaceuticals employees rate the overall compensation and benefits package 4.2/5 stars. What is the highest salary at Ironwood

Glassdoor.com

Category:  Pharmaceutical Detail Drugs


Ironwood Pharmaceuticals Jobs and Company Culture

(6 days ago) Ironwood Pharmaceuticals is more than just a company—it’s a group of people, each with unique perspectives and talents, who come together to create medicines that improve the lives of gastrointestinal (GI) patients. Joining Ironwood means becoming part of a diverse, inclusive, and collaborative team of individuals who like to challenge each

Themuse.com

Category:  Pharmaceutical Detail Drugs


Ironwood Pharmaceuticals Inc (IRWD) CEO Thomas A Mccourt

(3 days ago) CEO of Ironwood Pharmaceuticals Inc (30-Year Financial, Insider Trades) Thomas A Mccourt (insider trades) sold 46,327 shares of IRWD on 12/22/2021 at an average price of $11.41 a share.

Finance.yahoo.com

Category:  Pharmaceutical Detail Drugs


Insider Sell: Ironwood Pharmaceuticals MarketScreener

(8 days ago) Ironwood Pharmaceuticals to Present at the 40th Annual J.P. Morgan Healthcare Conferenc.. BU. 2021. INSIDER SELL : Ironwood Pharmaceuticals. MT. 2021. Ironwood Pharmaceuticals Hires Sravan Emany as Chief Financial Officer. MT. 2021.

Marketscreener.com

Category:  Pharmaceutical,  Health Detail Drugs


Ironwood Pharmaceuticals sees FY21 guidance ahead of prior

(7 days ago) Ironwood Pharmaceuticals (IRWD-0.6%) sees FY21 LINZESS U.S. net sales to exceed $1B with LINZESS U.S. net sales growth, total Ironwood revenues, and Ironwood adjusted EBITDA to be at the high end

Seekingalpha.com

Category:  Pharmaceutical Detail Drugs


Ironwood Pharmaceuticals - TRIA

(4 days ago) Ironwood Pharmaceuticals. TRIA’s design for Ironwood’s new headquarters is intended to provide an efficient and collaborative workspace in an open concept office plan. Collaboration areas with soft seating will be interspersed to create neighborhoods throughout the open office, which will also offer bench seating and personal lockers.

Tria.design

Category:  Pharmaceutical Detail Drugs


Working at Ironwood Pharmaceuticals Glassdoor

(2 days ago) The process took 1 week. I interviewed at Ironwood Pharmaceuticals (Boston, MA) in Dec 2021. Interview. Efficient interview process with short turnaround. Very friendly and flexible scheduling. Got constructive feedback to help with professional development. Got the chance to talk to stakeholders and collaborators, and also supervisors. Interview.

Glassdoor.com

Category:  Pharmaceutical Detail Drugs


Ironwood Pharmaceuticals, Inc. (IRWD) Stock Price Today

(6 days ago) A high-level overview of Ironwood Pharmaceuticals, Inc. (IRWD) stock. Stay up to date on the latest stock price, chart, news, analysis, …

Seekingalpha.com

Category:  Pharmaceutical Detail Drugs


Current Report Filing (8-k)

(6 days ago) IRWD Ironwood Pharmaceuticals Inc Current Report Filing (8-k) Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Ih.advfn.com

Category:  Pharmaceutical Detail Drugs


Ironwood Pharmaceuticals, inc (IRWD) Q3 2021 Earnings Call

(9 days ago) Ironwood Pharmaceuticals, inc (IRWD) Q3 2021 Earnings Call Transcript Motley Fool Transcribers 1 day ago Covid-19 hospitalizations are rising in Colorado, which has fewer than 100 open ICU beds

Msn.com

Category:  Pharmaceutical,  Hospital Detail Drugs


Ironwood Pharmaceuticals EquityNet

(2 days ago) Ironwood Pharmaceuticals, Inc., an entrepreneurial pharmaceutical company, engages in developing and marketing human medicines. It engages in developing a pipeline of clinical candidates in the areas of gastrointestinal diseases, cardiovascular diseases, pain, and inflammation. The company's operationally independent subsidiary, Microbia Inc., engages in …

Equitynet.com

Category:  Pharmaceutical Detail Drugs


Ironwood Pharmaceuticals to Present at the 40th Annual J.P

(Just Now) Ironwood Pharmaceuticals (Nasdaq: IRWD) is a leading gastrointestinal (GI) healthcare company on a mission to advance the treatment of GI diseases and redefine the standard of care for GI patients. We are pioneers in the development of LINZESS® (linaclotide), the U.S. branded prescription market leader for adults with irritable bowel syndrome

Biospace.com

Category:  Pharmaceutical,  Health Detail Drugs


Peptide-Based Gastrointestinal Disorders Therapeutics

(7 days ago) 2 days ago · In 2016, Ironwood Pharmaceuticals, Inc.’s collaboration with Astellas Pharma Inc. acquired trade authorization from the Japanese Ministry of …

Medgadget.com

Category:  Pharmaceutical Detail Drugs


Here is What Hedge Funds Think About Ironwood

(Just Now) Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) has experienced a decrease in hedge fund interest recently. Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) was in 27 hedge funds' portfolios at the end of September. The all time high for this statistic is 32. There were 28 hedge funds in our database with IRWD holdings at the end of June.

News.yahoo.com

Category:  Pharmaceutical Detail Drugs


Ironwood Pharmaceuticals to Present at the 40th Annual J.P

(6 days ago) Ironwood Pharmaceuticals (Nasdaq: IRWD) is a leading gastrointestinal (GI) healthcare company on a mission to advance the treatment of GI diseases and redefine the standard of care for GI patients

Streetinsider.com

Category:  Pharmaceutical,  Health Detail Drugs


Ironwood Pharmaceuticals - Overview, News & Competitors

(5 days ago) Ironwood Pharmaceuticals to Present at the 40th Annual J.P. Morgan Healthcare Conference BOSTON--(BUSINESS WIRE)--Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD), a GI-focused healthcare company, today announced that Tom McCourt, CEO, will present at the 40th Annual J.P. Morgan Healthcare Conference on Wednesday, January 12, 2022 at 7:30 a.m. ET.

Zoominfo.com

Category:  Pharmaceutical,  Health Detail Drugs


Ironwood Pharmaceuticals, Inc. (IRWD) Stock Price, Quote

(8 days ago) Ironwood Pharmaceuticals Provides Update on FY 2021 Financial Guidance and Announces FY 2022 Financial Guidance. BOSTON--(BUSINESS WIRE)--Ironwood Pharmaceuticals, Inc. (Nasdaq: IRWD), a GI-focused healthcare company, today provided updated financial guidance for full year 2021 and announced financial guidance for

Stockanalysis.com

Category:  Pharmaceutical,  Health Detail Drugs


Ironwood to cut 35% of staff after halting work on acid

(2 days ago) Ironwood to cut 35% of staff after halting work on acid reflux drug. One of Massachusetts’ few home-grown commercial drugmakers, Ironwood Pharmaceuticals Inc., is laying off 35% of its staff

Bizjournals.com

Category:  Pharmaceutical Detail Drugs


Ironwood to cut 100 jobs after acid reflux drug fails study

(7 days ago) Dania Nadeem. (Reuters) - Ironwood Pharmaceuticals Inc <IRWD.O> said on Tuesday it will cut about 100 jobs after its therapy to treat digestive disorder refractory gastroesophageal reflux failed to significantly reduce heartburn severity in a late-stage trial. Shares of the drugmaker fell 8% to $8.80, after the company also said it would

News.yahoo.com

Category:  Pharmaceutical,  Heart Detail Drugs


Ironwood Pharmaceuticals – Working Knowledge

(8 days ago) Ironwood Pharmaceuticals Working Knowledge CSP knowledge management consultants deliver practical understanding and application of knowledge management concepts, strategy, implementing practices, and “fit for purpose” knowledge management technologies to help organizations solve business and operational challenges affecting organization

Workingknowledge-csp.com

Category:  Pharmaceutical Detail Drugs


CJASN Editorial Team Disclosures 2018 Merged

(6 days ago) Consultancy Agreements: Boehringer-Ingelheim, Ironwood Pharmaceuticals Ownership Interests: n/a Research Funding: MedTronic (research equipment and supplies), Abbott (research supplies) Honoraria: n/a Patents and Inventions: n/a Scientific Advisor/Membership: Deputy Editor: Clinical Journal of the American Society of Nephrology

Cjasn.asnjournals.org

Category:  Pharmaceutical Detail Drugs


Ironwood Pharmaceuticals Inc - Company Profile and News

(9 days ago) Ironwood Pharmaceuticals, Inc. operates as a pharmaceutical company. The Company discovers, develops, manufactures, and commercializes marketed drugs. Ironwood products used in treatments of

Bloomberg.com

Category:  Pharmaceutical Detail Drugs


Ironwood Pharmaceuticals - IRWD - Stock Price Today - Zacks

(8 days ago) View Ironwood Pharmaceuticals, Inc. IRWD investment & stock information. Get the latest Ironwood Pharmaceuticals, Inc. IRWD detailed stock quotes, stock data, Real-Time ECN, charts, stats and more.

Zacks.com

Category:  Pharmaceutical Detail Drugs


Ironwood Pharmaceuticals Provides Update on FY 2021

(9 days ago) Ironwood Pharmaceuticals (Nasdaq: IRWD) is a leading gastrointestinal (GI) healthcare company on a mission to advance the treatment of GI diseases and redefine the standard of care for GI patients

Streetinsider.com

Category:  Pharmaceutical,  Health Detail Drugs


Ironwood Pharmaceuticals Provides Update on FY 2021

(4 days ago) Ironwood Pharmaceuticals, Inc. (Nasdaq: IRWD), a GI-focused healthcare company, today provided updated financial guidance for full year 2021 and announced financial guidance for full year 2022. The results were announced in advance of the Company’s presentation at the 40th Annual J.P. Morgan

Apnews.com

Category:  Pharmaceutical,  Health Detail Drugs


CJASN Editorial Team Disclosures 2019 Rajnish Mehrotra, MD

(8 days ago) CJASN Editorial Team Disclosures 2019 Page 1 of 33 June 19, 2019 Ian H. de Boer, MD, MS Deputy Editor Organization: Division of Nephrology and Kidney Research Institute, University of Washington Employer: University of Washington Consultancy Agreements: Boehringer-Ingelheim, Ironwood Pharmaceuticals

Cjasn.asnjournals.org

Category:  Pharmaceutical Detail Drugs


Working At Ironwood Pharmaceuticals - Zippia

(1 days ago) The average employee at Ironwood Pharmaceuticals makes $92,841 per year, which is competitive for its industry and location. Some of its highest paying competitors, Karyopharm Therapeutics, Allergan, and Amylin Pharmaceuticals, pay $97,763, $94,157, and $92,758, respectively. Ironwood Pharmaceuticals is a medium pharmaceutical company with …

Zippia.com

Category:  Pharmaceutical Detail Drugs


Ironwood Pharmaceuticals Inc Class A (IRWD) Quote - XNAS

(Just Now) Ironwood Pharmaceuticals is a specialty and generic drug manufacturing company that operates a human therapeutics segment. The company is focused on advancing innovative product opportunities in

Morningstar.com

Category:  Pharmaceutical Detail Drugs


Ironwood Pharmaceuticals: Jobs LinkedIn

(2 days ago) Ironwood Pharmaceuticals Pharmaceuticals Boston, MA 25,419 followers Ironwood is on a mission to advance treatment of gastrointestinal diseases …

Linkedin.com

Category:  Pharmaceutical Detail Drugs

Filter Type:


Popular Searched

 › Myuhcmedicare hwp order forms

 › Aetna drug tier list

 › Texas drug and alcohol class

 › Maryland board of pharmacy renewal

 › Alabama medicaid drug formulary

 › Respiratory drugs cheat sheet

 › Florida drug wholesale license verification

 › Aetna drug tier chart

 › Humana specialty pharmacy list

 › Maryland pharmacy technician license renewal

Recently Searched

 › Veterinary medical math practice problems

 › Sunrise hospital las vegas nevada

 › New healthcare reform bill

 › Senior care plus drug formulary

 › Bmc shapiro pharmacy phone number

 › Healthstream ou medical center okc

 › Breast cancer chemo drug

 › Hipaa can employers ask medical conditions

 › Aetna drug tier chart

 › Shopping drugsourceinc.com upmc medicare

FAQ about Ironwood Pharmaceuticals

What is ironironwood Pharmaceuticals Inc?

Ironwood Pharmaceuticals, Inc is a publicly traded pharmaceutical company. It was originally called Microbia, Inc..

Will Ironwood Pharmaceuticals present at the JP Morgan Healthcare Conference in 2022?

BOSTON, January 05, 2022--Ironwood Pharmaceuticals, Inc. (NASDAQ: IRWD), a GI-focused healthcare company, today announced that Tom McCourt, CEO, will present at the 40th Annual J.P. Morgan Healthcare Conference on Wednesday, January 12, 2022 at 7:30 a.m. ET.

Does ironironwood (IRWD) stock deliver strong earnings and revenue surprises?

Ironwood (IRWD) delivered earnings and revenue surprises of 6.45% and -1.32%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?

What happened to the anxiolytic that Ironwood abandoned?

BNC210 is an anxiolytic that Ironwood licensed and performed R&D on and then abandoned. In April 2018, the shares of Ironwood Pharmaceuticals closed up more than 10 percent on the news of biotech activist investor, Alex Denner joining its board.